Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which she says she experienced when taking opioids.

Approval of Journavx for acute pain marks the first new class of acute pain medication approved by the FDA in over 20 years.